Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick C Wilson

Showing results (81-90 of 173) with videos related to

Pageof 18
Sort By:
NPJ Vaccines|December 12, 2025
Characterization and immunogenicity of nanoparticle vaccines based on Clade 2 and Clade 3 sarbecovirus S2 proteinsPeter J Halfmann, Raj S Patel, Augustine Duffy, et al.
Analytical Chemistry|July 10, 2018
Crowd on a Chip: Label-Free Human Monoclonal Antibody Arrays for Serotyping InfluenzaHanyuan Zhang, Carole Henry, Christopher S Anderson, et al.
Plos Pathogens|August 25, 2023
Germline-encoded specificities and the predictability of the B cell responseMarcos C Vieira, Anna-Karin E Palm, Christopher T Stamper, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2023
IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent bindingMarcus J Bolton, Jefferson J S Santos, Claudia P Arevalo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 12, 2010
Rapid generation of rotavirus-specific human monoclonal antibodies from small-intestinal mucosaRoberto Di Niro, Luka Mesin, Melinda Raki, et al.
Transplantation|December 25, 2013
Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipientsMichelle Cowan, W James Chon, Amishi Desai, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2017
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strainsSeth J Zost, Kaela Parkhouse, Megan E Gumina, et al.
Mbio|April 5, 2018
NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?Florian Krammer, Ron A M Fouchier, Maryna C Eichelberger, et al.
Journal of Virology|October 20, 2021
Human Anti-neuraminidase Antibodies Reduce Airborne Transmission of Clinical Influenza Virus Isolates in the Guinea Pig ModelJessica Tan, George O'Dell, Matthew M Hernandez, et al.
Journal of Virology|June 15, 2018
Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 ChallengeRaffael Nachbagauer, David Shore, Hua Yang, et al.
Pageof 18

Showing results (81-90 of 173) with videos related to

Sort By:
Pageof 18
NPJ Vaccines|December 12, 2025
Characterization and immunogenicity of nanoparticle vaccines based on Clade 2 and Clade 3 sarbecovirus S2 proteinsPeter J Halfmann, Raj S Patel, Augustine Duffy, et al.
Analytical Chemistry|July 10, 2018
Crowd on a Chip: Label-Free Human Monoclonal Antibody Arrays for Serotyping InfluenzaHanyuan Zhang, Carole Henry, Christopher S Anderson, et al.
Plos Pathogens|August 25, 2023
Germline-encoded specificities and the predictability of the B cell responseMarcos C Vieira, Anna-Karin E Palm, Christopher T Stamper, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2023
IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent bindingMarcus J Bolton, Jefferson J S Santos, Claudia P Arevalo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 12, 2010
Rapid generation of rotavirus-specific human monoclonal antibodies from small-intestinal mucosaRoberto Di Niro, Luka Mesin, Melinda Raki, et al.
Transplantation|December 25, 2013
Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipientsMichelle Cowan, W James Chon, Amishi Desai, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2017
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strainsSeth J Zost, Kaela Parkhouse, Megan E Gumina, et al.
Mbio|April 5, 2018
NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?Florian Krammer, Ron A M Fouchier, Maryna C Eichelberger, et al.
Journal of Virology|October 20, 2021
Human Anti-neuraminidase Antibodies Reduce Airborne Transmission of Clinical Influenza Virus Isolates in the Guinea Pig ModelJessica Tan, George O'Dell, Matthew M Hernandez, et al.
Journal of Virology|June 15, 2018
Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 ChallengeRaffael Nachbagauer, David Shore, Hua Yang, et al.
Pageof 18